LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Clinical trials for LOCALLY ADVANCED GASTRIC ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED GASTRIC ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED GASTRIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising combo shrinks stomach tumors before surgery in early trial
Disease control CompletedThis study tested giving the immunotherapy drug tislelizumab along with chemotherapy (XELOX) before surgery to people with a certain type of stomach or gastroesophageal junction cancer. The goal was to see if this combination could shrink tumors more effectively and safely before…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
Scientists hunt for clues to predict immunotherapy success in stomach cancer
Knowledge-focused CompletedThis study looked at 28 people with stomach or gastroesophageal junction cancer to find biological markers that can predict how well a combination of the immunotherapy drug tislelizumab and chemotherapy works before surgery. Researchers analyzed RNA from tumor samples and built a…
Matched conditions: LOCALLY ADVANCED GASTRIC ADENOCARCINOMA
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC